Assemblybio
2 known investors
Assembly Bio is a biotechnology company developing antiviral therapies for serious viral and liver diseases, including treatments for recurrent genital herpes and chronic hepatitis. It focuses on virology and liver disease research to create novel drug candidates.
Investors · 2
Frequently asked questions
- What does Assemblybio do?
- Assembly Bio is a biotechnology company developing antiviral therapies for serious viral and liver diseases, including treatments for recurrent genital herpes and chronic hepatitis. It focuses on virology and liver disease research to create novel drug candidates.
- Who are Assemblybio's investors?
- Assemblybio's investors include Avoro Capital Advisors, Longitude Capital.